21/06/2022 - 23:48
Natac to be a minority shareholder, providing our expertise for the production of Omega 3. Natac and IFFE FUTURA have agreed that Natac Group is to become a 20% shareholder of IFFE BIOTECH. ...
Read more09/06/2022 - 17:57
Natac is dedicated to investigating, developing, and sustainably manufacturing plant extracts and compounds of natural origin. We successfully acquired INOREAL significantly expanding Natac’...
Read more03/06/2022 - 15:19
Madrid, Wednesday, June 1st, 2022— Natac has opened an office in central Singapore, to expand its sales, logistics and commercial operations into the Asia Pacific region. Natac who are headq...
Read more10/06/2021 - 18:02
Hervás, June 2, 2021 – Natac Group, a Spanish biotechnology business group dedicated to the research, development, manufacture and commercialization of ingredients of natural origin, has inaugurate...
Read more05/04/2019 - 13:05
Madrid, April 5, 2019 - At Natac Group we are taking a strategic step to achieve our growth objective by expanding our product portfolio and augmenting our production capacity, which will allow us to ...
Read more01/05/2015 - 09:13
Natac adopts the herb GRAPE in the American Botanical Council’s Adopt-an-herb programme. This adoption makes us both happy and proud since we are helping ensure that the latest scientific and cli...
Read more13/01/2014 - 12:00
Natac in Diario Médico Natac appears as a front-line research-based pharmaceutical company in Diario Médico. Alejandro Arranz, CEO of Parque Científico de Madrid, highlights the high professiona...
Read more13/11/2013 - 11:52
Natac wins the Startup Competition in the Science & Biotech category! Antonio Delgado and José Carlos Quintela, Natac’s cofounders, attend a ceremony to receive the prize to Natac’s achievemen...
Read more
